Trial to Evaluate Safety, Tolerability, PK, and Mechanism of Action of Zasocitinib in Participants With Moderately-to-Severely Active Crohn’s Disease (ZODIAC)

Principal Investigator

Dr Alissa Walsh

Contact us

Email: emcrf@ouh.nhs.uk

IRAS number

1013471